Ask your health care provider about Fluzone
Intradermal or Fluzone High-Dose vaccine
Fluzone High-Dose vaccine is the first and only influenza vaccine designed specifically for people 65 years of age and older.3,5 It helps your body make antibodies, substances that can help detect and fight off viruses like influenza.1,6 As a result, when compared to traditional influenza vaccines, Fluzone High-Dose vaccine can provide a stronger immune response in older adults.1,6
There are many different types of flu.6 Fluzone High-Dose vaccine helps protect against the flu virus strains (subtypes A and type B) contained in the vaccine, and not everyone will get the same level of protection.1
Studies have shown that Fluzone High-Dose vaccine is safe for people ages 65 years and older.1 Fluzone High-Dose vaccine is given by injection (shot) in the arm. You may have soreness, mild pain, swelling, fever, headache, fatigue, and muscular pain.1 Fluzone High-Dose vaccine is not appropriate for everybody. Do not receive Fluzone High-Dose vaccine if you or your loved one:1
Is under 65 years of age1
Has ever had an allergic reaction to a flu vaccine1
Is allergic to eggs or egg products1
If you or a loved one is moderately or severely ill at the time of your vaccination, talk to a health care provider about whether or not to reschedule. Your doctor may recommend waiting until the illness has gone away. Typically, people with a mild illness can still get the vaccine.6
Are you ready for a flu vaccine? Find Fluzone High-Dose vaccine using the Fluzone Locator.
Fluzone, Fluzone Intradermal, and Fluzone High-Dose vaccines are inactivated influenza virus vaccines given for active immunization against influenza disease caused by influenza A and B strains contained in the vaccine.
Fluzone vaccine is intended for persons 6 months of age and older.
Fluzone Intradermal vaccine is intended for persons 18 through 64 years of age.
Fluzone High-Dose vaccine is intended for persons 65 years of age and older. Approval of Fluzone High-Dose vaccine is based on superior immune response relative to Fluzone vaccine. Data demonstrating a decrease in influenza disease after vaccination with Fluzone High-Dose vaccine relative to Fluzone vaccine are not available.
Side effects to Fluzone and Fluzone High-Dose vaccines include pain, redness, and swelling at the injection site; muscle aches, fatigue, headache, and fever (irritability, crying, and drowsiness in young children receiving Fluzone vaccine). Redness, firmness, swelling, and itching at the injection site occur more frequently with Fluzone Intradermal vaccine than with Fluzone vaccine. Other side effects may occur. Fluzone, Fluzone Intradermal, and Fluzone High-Dose vaccines should not be administered to anyone with a severe allergic reaction to any vaccine component, including eggs, egg products, or thimerosal (the only Fluzone vaccine product containing thimerosal is the multi-dose vial), or to a previous dose of any influenza vaccine.
Tell the doctor if you/your child has ever experienced Guillain-Barré syndrome (severe muscle weakness) after a previous dose of influenza vaccine. If you notice any other problems or symptoms following vaccination, please contact your health care professional immediately. Vaccination with Fluzone or Fluzone High-Dose vaccine may not protect all individuals.
For more information about Fluzone vaccine, talk to your health care professional and see complete Patient Information
For more information about Fluzone Intradermal vaccine, talk to your health care professional and see complete Patient Information
For more information about Fluzone High-Dose vaccine, talk to your health care professional and see complete Patient Information
By clicking on this link, you will be leaving this Sanofi Pasteur website and going to another, entirely independent website. Sanofi Pasteur provides this link as a service to its website visitors; however, it takes no responsibility for the information presented on any website but its own.
This link has opened in a new window. To return to your original site, please close this new window.Click here to go to the page you requested. Click here to close this window and return to the site.